Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors [Phase 1, Phase 2]
This Phase 1/2 trial compares the effects of recombinant human growth hormone (somatropin) versus recombinant human IGF-1 (mecasermin) on ca…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial [Phase 3]
A long-term Phase 3 trial evaluating the safety and efficacy of TransCon hGH in children with growth hormone deficiency who completed a prio…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency [Phase 3]
Phase 3 trial evaluating the efficacy and safety of recombinant long-acting human growth hormone (TJ101) in children with growth hormone def…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients [Phase 4]
Phase 4 clinical trial evaluating the effect of somatropin on left ventricular mass in adults with growth hormone deficiency has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) [Phase 2]
A long-term safety trial evaluating LUM-201 in children with idiopathic growth hormone deficiency who previously completed a LUM-201 trial (…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating safety and efficacy of a Y-shape pegylated somatropin in children with growth hormone defici…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212) [Phase 2]
Phase 2 PK/PD study update for LUM-201 in children with idiopathic growth hormone deficiency.
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency [Phase 3]
A Phase 3 trial evaluating weekly PEG-somatropin (GenSci004) for treatment-naive children with growth hormone deficiency to assess efficacy …
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency [Phase 3]
Phase 3 trial Update investigating once-weekly PEG-somatropin (GenSci004) for safety and efficacy in children with growth hormone deficiency…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD) [Phase 2]
Open-label extension of a Phase 2 study assessing long-term twice-monthly somavaratan in adults with growth hormone deficiency; study termin…
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Adult Growth Hormone Deficiency and Cardiovascular Risk [Phase 4]
Phase 4 clinical trial update on adult growth hormone deficiency and cardiovascular risk; study terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency [Phase 3]
Phase 3 trial evaluating MOD-4023 in adults with growth hormone deficiency was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Versartis International Trial in Adults With Long-Acting Growth Hormone [Phase 2]
Phase 2 clinical trial update for adults with growth hormone deficiency evaluating a long-acting growth hormone treatment.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Versartis Trial in Children to Assess Long-Acting Growth Hormone [Phase 1, Phase 2]
A clinical trial update for Versartis' long-acting growth hormone in children shows completion of Phase 1/Phase 2 studies for Pediatric Grow…
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317) [Phase 2, Phase 3]
A clinical trial update indicates termination of a study evaluating long-acting growth hormone somavaratan (VRS-317) in pre-pubertal Japanes…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency [Phase 2]
Phase 2 trial assessing safety, tolerability, and efficacy of weekly TV-1106 in adults with growth hormone deficiency has been completed.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD) [Phase 3]
Phase 3 study assessing safety and tolerability in adults with growth hormone deficiency has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD [Phase 3]
Phase 3 trial evaluating patient-perceived burden of weekly versus daily growth hormone injections in children with growth hormone deficienc…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? [Phase 4]
Phase 4 clinical trial update assessing sensitivity to growth hormone in children with Prader-Willi Syndrome and growth hormone deficiency.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency [Phase 3]
Phase 3 trial of MOD-4023 for growth hormone deficiency in children completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children [Phase 3]
Phase 3 trial evaluating long-acting growth hormone MOD-4023 in children with growth hormone deficiency reported safety and efficacy results…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency. [Phase 3]
Phase 3 trial comparing somapacitan with placebo and daily somatropin in adults with growth hormone deficiency has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency [Phase 3]
A Phase 3 trial comparing once-weekly somapacitan to daily Norditropin in adults previously treated for growth hormone deficiency; trial com…
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency [Phase 2]
Phase 2 dose-finding trial of GX-H9 in pediatric growth hormone deficiency has been completed.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency [Phase 3]
Phase 3 trial comparing TransCon hGH weekly to daily hGH in Chinese pediatric growth hormone deficiency assesses safety, tolerability, and e…